Cann Group revenue falls but losses narrow as focus turns to ‘critical’ restructuring of finances by Steve Jones March 1, 2025March 3, 2025 Cann Group shaved 25% off first-half losses and reduced expenditure but still fell heavily into the […]
News in brief: InhaleRx; Hemp Pet; Neurotech International; Cann Group by Martin Lane November 19, 2024November 19, 2024
Formal mediation fails to resolve Cann Group and Rua legal dispute but talks continue by Steve Jones October 30, 2024October 30, 2024
Cann Group faces more questions after reporting a bank balance of -$18,000 by Steve Jones October 23, 2024October 23, 2024
Cann Group cites positive press coverage as possible reason for share price surge by Martin Lane September 30, 2024January 13, 2025
Company news: Cann Group; Helius Therapeutics/Novachem; Elixinol/HFA by Martin Lane September 4, 2024January 13, 2025
Cann Group confirms Jenni Pilcher as MD and CEO after drawing up ‘well-defined strategy’ by Steve Jones July 18, 2024November 25, 2024
